Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 62.42 billion. The enterprise value is 110.82 billion.
Important Dates
The next estimated earnings date is Tuesday, February 2, 2027.
| Earnings Date | Feb 2, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Amicogen has 70.45 million shares outstanding. The number of shares has increased by 18.22% in one year.
| Current Share Class | 70.45M |
| Shares Outstanding | 70.45M |
| Shares Change (YoY) | +18.22% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 3.70% |
| Owned by Institutions (%) | 0.23% |
| Float | 64.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | 20.37 |
| P/OCF Ratio | 16.58 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 36.16 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.88 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | 17.95 |
| Interest Coverage | -2.04 |
Financial Efficiency
Return on equity (ROE) is -10.72% and return on invested capital (ROIC) is -6.95%.
| Return on Equity (ROE) | -10.72% |
| Return on Assets (ROA) | -5.36% |
| Return on Invested Capital (ROIC) | -6.95% |
| Return on Capital Employed (ROCE) | -8.60% |
| Weighted Average Cost of Capital (WACC) | 6.73% |
| Revenue Per Employee | 220.56M |
| Profits Per Employee | -52.17M |
| Employee Count | 218 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 3.85 |
Taxes
In the past 12 months, Amicogen has paid 655.26 million in taxes.
| Income Tax | 655.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.92% in the last 52 weeks. The beta is 0.13, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -69.92% |
| 50-Day Moving Average | 945.20 |
| 200-Day Moving Average | 1,319.65 |
| Relative Strength Index (RSI) | 41.16 |
| Average Volume (20 Days) | 388,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amicogen had revenue of KRW 48.08 billion and -11.37 billion in losses. Loss per share was -174.97.
| Revenue | 48.08B |
| Gross Profit | 8.57B |
| Operating Income | -12.46B |
| Pretax Income | -11.28B |
| Net Income | -11.37B |
| EBITDA | -4.16B |
| EBIT | -12.46B |
| Loss Per Share | -174.97 |
Full Income Statement Balance Sheet
The company has 7.52 billion in cash and 55.02 billion in debt, with a net cash position of -47.50 billion or -674.21 per share.
| Cash & Cash Equivalents | 7.52B |
| Total Debt | 55.02B |
| Net Cash | -47.50B |
| Net Cash Per Share | -674.21 |
| Equity (Book Value) | 110.97B |
| Book Value Per Share | 1,558.71 |
| Working Capital | -4.83B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 3.77 billion and capital expenditures -701.05 million, giving a free cash flow of 3.06 billion.
| Operating Cash Flow | 3.77B |
| Capital Expenditures | -701.05M |
| Depreciation & Amortization | 8.29B |
| Net Borrowing | -22.26B |
| Free Cash Flow | 3.06B |
| FCF Per Share | 43.50 |
Full Cash Flow Statement Margins
Gross margin is 17.82%, with operating and profit margins of -25.91% and -23.66%.
| Gross Margin | 17.82% |
| Operating Margin | -25.91% |
| Pretax Margin | -23.46% |
| Profit Margin | -23.66% |
| EBITDA Margin | -8.66% |
| EBIT Margin | -25.91% |
| FCF Margin | 6.37% |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 2.82%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 2.82% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -18.22% |
| Shareholder Yield | -15.40% |
| Earnings Yield | -19.75% |
| FCF Yield | 4.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Amicogen has an Altman Z-Score of 0.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.33 |
| Piotroski F-Score | 4 |